$45M Settlement Reached In Becton Hypodermic MDL
Becton Dickinson & Co. Inc. has reached a $45 million settlement with direct purchaser plaintiffs in five antitrust suits accusing the medical device maker of monopolizing the market for hypodermic products....To view the full article, register now.
Already a subscriber? Click here to view full article